Drugmaker Sanofi Partners Openai, Formation Bio On AI-Powered Drug Development
New Delhi, May 21 (IANS) French drugmaker Sanofi on Tuesday announced that it has partnered with artificial intelligence (AI) company OpenAI and tech
Stay updated with breaking news from Brad Lightcap. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
New Delhi, May 21 (IANS) French drugmaker Sanofi on Tuesday announced that it has partnered with artificial intelligence (AI) company OpenAI and tech
French drugmaker Sanofi on Tuesday announced that it has partnered with artificial intelligence (AI) company OpenAI and tech-driven pharmaceutical firm Formation Bio to build AI-powered software to boost drug development and bring new medicines ...
PARIS (dpa-AFX) - French drug major Sanofi is teaming with artificial intelligence or AI startup OpenAI, the developer of highly popular generative AI chatbot ChatGPT, as well as Formation Bio
Sanofi, Formation Bio and OpenAI are collaborating to build AI-powered software to accelerate drug development and bring new medicines to patients more efficiently. The three teams will bring together data, software and tuned models to develop custom, purpose-built solutions across the drug development lifecycle.
Here's a ChatGPT guide to help understand Open AI's viral text-generating system. We outline the most recent updates and answer your FAQs.